{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T17:46:48Z","timestamp":1792000008477,"version":"4.4.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:00:00Z","timestamp":1791936000000},"content-version":"vor","delay-in-days":86,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"DOI":"10.1038\/s41398-026-04307-9","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T09:07:02Z","timestamp":1784538422000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Revisiting the cognitive potential of lithium in alzheimer\u2019s disease: the role of cholinergic system and brain connectivity"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9305-3376","authenticated-orcid":false,"given":"Lorenzo","family":"Pini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0327-7262","authenticated-orcid":false,"given":"Bruno Pietro","family":"Imbimbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8075-4253","authenticated-orcid":false,"given":"Nunzio","family":"Pomara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,20]]},"reference":[{"key":"4307_CR1","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1038\/s41586-025-09335-x","volume":"645","author":"L Aron","year":"2025","unstructured":"Aron L, Ngian ZK, Qiu C, Choi J, Liang M, Drake DM, et al. Lithium deficiency and the onset of alzheimer\u2019s disease. Nature. 2025;645:712\u201321. https:\/\/doi.org\/10.1038\/s41586-025-09335-x.","journal-title":"Nature"},{"key":"4307_CR2","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1192\/bjp.bp.110.080044","volume":"198","author":"OV Forlenza","year":"2011","unstructured":"Forlenza OV, Diniz BS, Radanovic M, Santos FS, Talib LL, Gattaz WF. Disease-modifying properties of long-term lithium treatment for amnestic mild cognitive impairment: randomised controlled trial. Br J Psychiatry. 2011;198:351\u20136. https:\/\/doi.org\/10.1192\/bjp.bp.110.080044.","journal-title":"Br J Psychiatry"},{"key":"4307_CR3","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1192\/bjp.2019.76","volume":"215","author":"OV Forlenza","year":"2019","unstructured":"Forlenza OV, Radanovic M, Talib LL, Gattaz WF. Clinical and biological effects of long-term lithium treatment in older adults with amnestic mild cognitive impairment: randomised clinical trial. Br J Psychiatry. 2019;215:668\u201374. https:\/\/doi.org\/10.1192\/bjp.2019.76.","journal-title":"Br J Psychiatry"},{"key":"4307_CR4","doi-asserted-by":"publisher","first-page":"922","DOI":"10.4088\/JCP.08m04606","volume":"70","author":"H Hampel","year":"2009","unstructured":"Hampel H, Ewers M, B\u00fcrger K, Annas P, M\u00f6rtberg A, Bogstedt A, et al. Lithium trial in alzheimer\u2019s disease: a randomized, single-blind, placebo-controlled, multicenter 10-week study. J Clin Psychiatry. 2009;70:922\u201331.","journal-title":"J Clin Psychiatry"},{"key":"4307_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2025.106458","volume":"180","author":"T Kishi","year":"2026","unstructured":"Kishi T, Matsunaga S, Saito Y, Iwata N. Lithium for alzheimer\u2019s disease: insights from a meta-analysis. Neurosci Biobehav Rev. 2026;180:106458. https:\/\/doi.org\/10.1016\/j.neubiorev.2025.106458.","journal-title":"Neurosci Biobehav Rev"},{"key":"4307_CR6","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/0364-7722(80)90067-3","volume":"4","author":"SJ Choi","year":"1980","unstructured":"Choi SJ, Derman RM. Lithium and cholinesterase. Prog Neuro-Psychopharmacology gennaio. 1980;4:107\u20139. https:\/\/doi.org\/10.1016\/0364-7722(80)90067-3.","journal-title":"Prog Neuro-Psychopharmacology gennaio"},{"key":"4307_CR7","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1176\/ajp.140.7.911","volume":"140","author":"N Pomara","year":"1983","unstructured":"Pomara N, Banay-Schwartz M, Block R, Stanley M, Gershon S. Elevation of RBC glycine and choline levels in geriatric patients treated with lithium. AJP 1 luglio. 1983;140:911\u20133. https:\/\/doi.org\/10.1176\/ajp.140.7.911.","journal-title":"AJP 1 luglio"},{"key":"4307_CR8","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s00213-009-1510-y","volume":"205","author":"N Pomara","year":"2009","unstructured":"Pomara N. Lithium treatment in alzheimer\u2019s disease does not promote cognitive enhancement, but may exert long-term neuroprotective effects. Psychopharmacology. 2009;205:169\u201370. https:\/\/doi.org\/10.1007\/s00213-009-1510-y.","journal-title":"Psychopharmacology"},{"key":"4307_CR9","first-page":"157","volume":"19","author":"S Brinkman","year":"1984","unstructured":"Brinkman S, Pomara N, Barnett N, Block R, Domino E, Gershon S. Lithium-induced increases in red blood cell choline and memory performance in alzheimer-type dementia. Biol Psychiatry. 1984;19:157\u201364.","journal-title":"Biol Psychiatry"},{"key":"4307_CR10","first-page":"919","volume":"19","author":"N Pomara","year":"1984","unstructured":"Pomara N, Block R, Domino E, Gershon S. Decay in plasma lithium and normalization in red blood cell choline following cessation of lithium treatment in two elderly individuals with alzheimer-type dementia. Biol Psychiatry. 1984;19:919\u201322.","journal-title":"Biol Psychiatry"},{"key":"4307_CR11","first-page":"342","volume":"45","author":"S Kelwala","year":"1984","unstructured":"Kelwala S, Pomara N, Stanley M, Sitaram N, Gershon S. Lithium-induced accentuation of extrapyramidal symptoms in individuals with alzheimer\u2019s disease. J Clin Psychiatry. 1984;45:342\u20134.","journal-title":"J Clin Psychiatry"},{"key":"4307_CR12","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/nature01339","volume":"421","author":"H Wang","year":"2003","unstructured":"Wang H, Yu M, Ochani M, Amella CA, Tanovic M, Susarla S, et al. Nicotinic acetylcholine receptor \u03b17 subunit is an essential regulator of inflammation. Nature. 2003;421:384\u20138. https:\/\/doi.org\/10.1038\/nature01339.","journal-title":"Nature"},{"key":"4307_CR13","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.brainres.2009.01.069","volume":"1265","author":"RS Bitner","year":"2009","unstructured":"Bitner RS, Nikkel AL, Markosyan S, Otte S, Puttfarcken P, Gopalakrishnan M. Selective \u03b17 nicotinic acetylcholine receptor activation regulates glycogen synthase kinase3\u03b2 and decreases tau phosphorylation in vivo. Brain Res. 2009;1265:65\u201374. https:\/\/doi.org\/10.1016\/j.brainres.2009.01.069.","journal-title":"Brain Res"},{"key":"4307_CR14","doi-asserted-by":"publisher","first-page":"4124","DOI":"10.1002\/cne.23415","volume":"521","author":"M Mesulam","year":"2013","unstructured":"Mesulam M. -Marsel. Cholinergic circuitry of the human nucleus basalis and its fate in Alzheimer\u2019s disease. J Comp Neurol. 2013;521:4124\u201344. https:\/\/doi.org\/10.1002\/cne.23415.","journal-title":"J Comp Neurol"},{"key":"4307_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2020.116607","volume":"211","author":"M Nemy","year":"2020","unstructured":"Nemy M, Cedres N, Grothe MJ, Muehlboeck JS, Lindberg O, Nedelska Z, et al. Cholinergic white matter pathways make a stronger contribution to attention and memory in normal aging than cerebrovascular health and nucleus basalis of meynert. NeuroImage. 2020;211:116607. https:\/\/doi.org\/10.1016\/j.neuroimage.2020.116607.","journal-title":"NeuroImage"},{"key":"4307_CR16","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1093\/brain\/awab372","volume":"145","author":"J Schumacher","year":"2022","unstructured":"Schumacher J, Ray NJ, Hamilton CA, Donaghy PC, Firbank M, Roberts G, et al. Cholinergic white matter pathways in dementia with lewy bodies and alzheimer\u2019s disease. Brain. 2022;145:1773\u201384. https:\/\/doi.org\/10.1093\/brain\/awab372.","journal-title":"Brain"},{"key":"4307_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/srep09748","volume":"5","author":"R Bajo","year":"2015","unstructured":"Bajo R, Pusil S, L\u00f3pez ME, Canuet L, Pereda E, Osipova D, et al. Scopolamine effects on functional brain connectivity: a pharmacological model of alzheimer\u2019s disease. Sci Rep. 2015;5:9748. https:\/\/doi.org\/10.1038\/srep09748.","journal-title":"Sci Rep"},{"key":"4307_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-41025-y","volume":"14","author":"T Gedankien","year":"2023","unstructured":"Gedankien T, Tan RJ, Qasim SE, Moore H, McDonagh D, Jacobs J, et al. Acetylcholine modulates the temporal dynamics of human theta oscillations during memory. Nat Commun. 2023;14:5283. https:\/\/doi.org\/10.1038\/s41467-023-41025-y.","journal-title":"Nat Commun"},{"key":"4307_CR19","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/j.neuroimage.2011.12.077","volume":"60","author":"W Li","year":"2012","unstructured":"Li W, Antuono PG, Xie C, Chen G, Jones JL, Ward BD, et al. Changes in regional cerebral blood flow and functional connectivity in the cholinergic pathway associated with cognitive performance in subjects with mild alzheimer\u2019s disease after 12-week donepezil treatment. NeuroImage. 2012;60:1083\u201391. https:\/\/doi.org\/10.1016\/j.neuroimage.2011.12.077.","journal-title":"NeuroImage"},{"key":"4307_CR20","doi-asserted-by":"publisher","first-page":"awaf404","DOI":"10.1093\/brain\/awaf404","volume":"149","author":"L Pini","year":"2025","unstructured":"Pini L, Allali G, Imbimbo BP, Germani M, Corbetta M. Brain connectivity as a new target for alzheimer\u2019s disease therapy?. Brain. 2025;149:awaf404 https:\/\/doi.org\/10.1093\/brain\/awaf404.","journal-title":"Brain"},{"key":"4307_CR21","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/bdi.12718","volume":"21","author":"JM Spielberg","year":"2019","unstructured":"Spielberg JM, Matyi MA, Karne H, Anand A. Lithium monotherapy associated longitudinal effects on resting state brain networks in clinical treatment of bipolar disorder. Bipolar Disord. 2019;21:361\u201371. https:\/\/doi.org\/10.1111\/bdi.12718.","journal-title":"Bipolar Disord"},{"key":"4307_CR22","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1007\/s40263-021-00869-y","volume":"35","author":"E Bergamelli","year":"2021","unstructured":"Bergamelli E, Del Fabro L, Delvecchio G, D\u2019Agostino A, Brambilla P. The impact of lithium on brain function in bipolar disorder: an updated review of functional magnetic resonance imaging studies. CNS Drugs. 2021;35:1275\u201387. https:\/\/doi.org\/10.1007\/s40263-021-00869-y.","journal-title":"CNS Drugs"},{"key":"4307_CR23","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1111\/bdi.12260","volume":"17","author":"AG Gildengers","year":"2015","unstructured":"Gildengers AG, Butters MA, Aizenstein HJ, Marron MM, Emanuel J, Anderson SJ, et al. Longer lithium exposure is associated with better white matter integrity in older adults with bipolar disorder. Bipolar Disord. 2015;17:248\u201356. https:\/\/doi.org\/10.1111\/bdi.12260.","journal-title":"Bipolar Disord"},{"key":"4307_CR24","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1038\/s41380-018-0016-6","volume":"23","author":"FE Smith","year":"2018","unstructured":"Smith FE, Thelwall PE, Necus J, Flowers CJ, Blamire AM, Cousins DA. 3D 7Li magnetic resonance imaging of brain lithium distribution in bipolar disorder. Mol Psychiatry. 2018;23:2184\u201391. https:\/\/doi.org\/10.1038\/s41380-018-0016-6.","journal-title":"Mol Psychiatry"},{"key":"4307_CR25","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.biopsych.2020.02.1181","volume":"88","author":"J Stout","year":"2020","unstructured":"Stout J, Hozer F, Coste A, Mauconduit F, Djebrani-Oussedik N, Sarrazin S, et al. Accumulation of lithium in the hippocampus of patients with bipolar disorder: a lithium-7 magnetic resonance imaging study at 7 tesla. Biol Psychiatry. 2020;88:426\u201333. https:\/\/doi.org\/10.1016\/j.biopsych.2020.02.1181.","journal-title":"Biol Psychiatry"},{"key":"4307_CR26","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.jad.2019.04.075","volume":"253","author":"J Necus","year":"2019","unstructured":"Necus J, Sinha N, Smith FE, Thelwall PE, Flowers CJ, Taylor PN, et al. White matter microstructural properties in bipolar disorder in relationship to the spatial distribution of lithium in the brain. J Affect Disord. 2019;253:224\u201331. https:\/\/doi.org\/10.1016\/j.jad.2019.04.075.","journal-title":"J Affect Disord"},{"key":"4307_CR27","doi-asserted-by":"publisher","first-page":"104","DOI":"10.2174\/1567205011310010014","volume":"10","author":"M Andrade Nunes","year":"2013","unstructured":"Andrade Nunes M, Araujo Viel T, Sousa Buck H. Microdose lithium treatment stabilized cognitive impairment in patients with alzheimer\u2019s disease. CAR. 2013;10:104\u20137. https:\/\/doi.org\/10.2174\/1567205011310010014.","journal-title":"CAR"},{"key":"4307_CR28","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.neulet.2007.09.074","volume":"429","author":"ES Monkul","year":"2007","unstructured":"Monkul ES, Matsuo K, Nicoletti MA, Dierschke N, Hatch JP, Dalwani M, et al. Prefrontal gray matter increases in healthy individuals after lithium treatment: a voxel-based morphometry study. Neurosci Lett. 2007;429:7\u201311. https:\/\/doi.org\/10.1016\/j.neulet.2007.09.074.","journal-title":"Neurosci Lett"},{"key":"4307_CR29","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.jad.2024.05.128","volume":"360","author":"MA Neal","year":"2024","unstructured":"Neal MA, Strawbridge R, Wing VC, Cousins DA, Thelwall PE. Human brain 7Li-MRI following low-dose lithium dietary supplementation in healthy participants. J Affect Disord. 2024;360:139\u201345. https:\/\/doi.org\/10.1016\/j.jad.2024.05.128.","journal-title":"J Affect Disord"},{"key":"4307_CR30","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1001\/jamaneurol.2026.0072","volume":"83","author":"AG Gildengers","year":"2026","unstructured":"Gildengers AG, Ibrahim TS, Anderson SJ, Emanuel JE, Santini T, Diaz JL, et al. Low-dose lithium for mild cognitive impairment: a pilot randomized clinical trial. JAMA Neurol. 2026;83:310 https:\/\/doi.org\/10.1001\/jamaneurol.2026.0072.","journal-title":"JAMA Neurol"},{"key":"4307_CR31","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1212\/WNL.0000000000002923","volume":"87","author":"CR Jack","year":"2016","unstructured":"Jack CR, Bennett DA, Blennow K, Carrillo MC, Feldman HH, Frisoni GB, et al. A\/T\/N: An unbiased descriptive classification scheme for alzheimer disease biomarkers. Neurology. 2016;87:539\u201347. https:\/\/doi.org\/10.1212\/WNL.0000000000002923.","journal-title":"Neurology"},{"key":"4307_CR32","doi-asserted-by":"publisher","first-page":"4323","DOI":"10.1523\/JNEUROSCI.3263-16.2017","volume":"37","author":"AP Schultz","year":"2017","unstructured":"Schultz AP, Chhatwal JP, Hedden T, Mormino EC, Hanseeuw BJ, Sepulcre J, et al. Phases of hyperconnectivity and hypoconnectivity in the default mode and salience networks track with amyloid and tau in clinically normal individuals. J Neurosci. 2017;37:4323\u201331. https:\/\/doi.org\/10.1523\/JNEUROSCI.3263-16.2017.","journal-title":"J Neurosci"},{"key":"4307_CR33","doi-asserted-by":"publisher","first-page":"115","DOI":"10.4103\/1673-5374.340410","volume":"18","author":"L Pini","year":"2023","unstructured":"Pini L. Brain network modulation in alzheimer\u2019s disease: clinical phenotypes and windows of opportunity. Neural Regen Res. 2023;18:115. https:\/\/doi.org\/10.4103\/1673-5374.340410.","journal-title":"Neural Regen Res"},{"key":"4307_CR34","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1038\/nrn.2016.141","volume":"17","author":"JJ Palop","year":"2016","unstructured":"Palop JJ, Mucke L. Network abnormalities and interneuron dysfunction in alzheimer disease. Nat Rev Neurosci. 2016;17:777\u201392. https:\/\/doi.org\/10.1038\/nrn.2016.141.","journal-title":"Nat Rev Neurosci"},{"key":"4307_CR35","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1001\/jama.2025.21738","volume":"335","author":"DP Devanand","year":"2025","unstructured":"Devanand DP, Wisniewski T, Razlighi Q, Qian M, Wei R, Andrews HF, et al. Valacyclovir treatment of early symptomatic alzheimer disease: the VALAD randomized clinical trial. JAMA. 2025;335:511\u201322. https:\/\/doi.org\/10.1001\/jama.2025.21738.","journal-title":"JAMA"},{"key":"4307_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s40345-016-0068-y","volume":"4","author":"M Gitlin","year":"2016","unstructured":"Gitlin M. Lithium side effects and toxicity: prevalence and management strategies. Int J Bipolar Disord. 2016;4:27. https:\/\/doi.org\/10.1186\/s40345-016-0068-y.","journal-title":"Int J Bipolar Disord"},{"key":"4307_CR37","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.expneurol.2018.02.011","volume":"304","author":"RN Ruggiero","year":"2018","unstructured":"Ruggiero RN, Rossignoli MT, Lopes-Aguiar C, Leite JP, Bueno-Junior LS, Romcy-Pereira RN. Lithium modulates the muscarinic facilitation of synaptic plasticity and theta-gamma coupling in the hippocampal-prefrontal pathway. Exp Neurol. 2018;304:90\u2013101. https:\/\/doi.org\/10.1016\/j.expneurol.2018.02.011.","journal-title":"Exp Neurol"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-04307-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-04307-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-04307-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T17:01:57Z","timestamp":1791997317000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-04307-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,20]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4307"],"URL":"https:\/\/doi.org\/10.1038\/s41398-026-04307-9","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,20]]},"assertion":[{"value":"20 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr. Lorenzo Pini reported a patent (Italian number 102022000015360 and PCT IB2023\/057357) for a method using structural disconnections for predicting clinical outcomes. Dr. Bruno P. Imbimbo is an employee at Chiesi Farmaceutici. He is listed among the inventors of a number of Chiesi Farmaceutici\u2019s patents of anti-Alzheimer drugs. Prof. Nunzio Pomara has served as an investigator in several anti-Alzheimer\u2019s and antidepressant drug trials. He holds a joint patent with New York University on a subtype of depression associated with disturbances in A\u03b2 dynamics.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"560"}}